Praxis Precision Medicines (PRAX) Accumulated Expenses (2019 - 2026)

Praxis Precision Medicines' Accumulated Expenses history runs 8 years deep, the most recent figure standing at $17.6 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 13.51% year-over-year to $17.6 million; the TTM figure through Mar 2026 stood at $17.6 million (up 13.51% YoY), while the FY2025 annual figure was $35.0 million, up 47.43% from the prior year.
• Accumulated Expenses was $17.6 million for Q1 2026 at Praxis Precision Medicines, down from $35.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $35.0 million in Q4 2025 to a low of $7.0 million in Q1 2024.
• Historically, Accumulated Expenses has averaged $17.2 million across 5 years, with a median of $15.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses jumped 318.75% in 2022, then slumped 69.76% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $15.8 million in 2022, then sank by 53.21% to $7.4 million in 2023, then jumped by 220.43% to $23.8 million in 2024, then soared by 47.43% to $35.0 million in 2025, then tumbled by 49.62% to $17.6 million in 2026.
• The last three Accumulated Expenses figures came in at $17.6 million (Q1 2026), $35.0 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.